
Genetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.
The global market for prescription drugs will grow from $950 billion now to $1.2 trillion in 2016, according to a new report released today. But Big Pharma may sit out much of the growth as patents on big-selling drugs expire and people fast-growing markets such as China, Russia, and Brazil buy generic drugs from local manufacturers.
Read the full story:
Source: Forbes





